International Chronic Ocular Graft-vs-Host Disease (GVHD) Consensus Group: Proposal of New Diagnostic Criteria for Chronic GVHD
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Scottsdale/Phoenix, Arizona: 18-000413
Sponsor Protocol Number: 18-000413
About this study
The aim of this multicenter study is to prospectively collect anonymous data at international cancer centers from eye exams after development of dry eye symptoms and ocular GVHD in patients status post stem cell transplant for hematological disorders.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Patient visiting Mayo Clinic in Arizona from November 2017 to March 31, 2020 Ophthalmology Department after HSCT at any participating investigators’ centers.
- New onset of dry eye after HSCT
- Completion of donor engraftment
- 21 years or older
- First HSCT only
Exclusion Criteria:
- Preexisting dry eye, prior to HSCT
- Other ocular surface disease including infection, allergic conjunctivitis, contact lens wearer, glaucoma, prior ophthalmic surgery
- 20 years or younger
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Scottsdale/Phoenix, Ariz.
Mayo Clinic principal investigator Joanne Shen, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available